Published in J Clin Invest on October 01, 1970
Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest (1974) 1.23
The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest (1971) 1.05
Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs. J Clin Invest (1974) 0.90
Effects of isoproterenol on regional myocardial function, electrogram, and blood flow in conscious dogs with myocardial ischemia. J Clin Invest (1976) 0.87
Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease. Br J Clin Pharmacol (1978) 0.75
The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J (1967) 12.40
Electrodes for blood pO2 and pCO2 determination. J Appl Physiol (1958) 7.93
Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol (1958) 7.03
Chemoreflexes from the heart and lungs. Physiol Rev (1954) 4.75
Control of concentration gradients of pyruvate and lactate across cell membranes in blood. J Appl Physiol (1956) 3.14
Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol (1965) 2.11
Action potentials in fibres from receptors in the epicardium and myocardium of the dog's left ventricle. J Physiol (1965) 1.95
Hemodynamic alterations in acute myocardial infarction. I. Cardiac output, mean arterial pressure, total peripheral resistance, central and total blood volumes, venous pressure and average circulation time. J Clin Invest (1952) 1.84
ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE. Am J Med (1964) 1.58
Coronary heart disease. Clinical, cinearteriographic and metabolic correlations. Am J Cardiol (1966) 1.57
Evaluation of use of left coronary artery inflow and O2 content of coronary sinus blood as a measure of left ventricular metabolism. J Appl Physiol (1959) 1.37
An electrocardiographic, anatomic, and metabolic study of zonal myocardial ischemia in coronary heart disease. Circulation (1967) 1.34
Extracardiac factors contributing to hypotension during coronary occlusion. Am J Cardiol (1963) 1.34
Left ventricular pressure-volume relationships and myocardial oxygen consumption in the isolated heart. Circ Res (1961) 1.31
Ineffectiveness of isoproterenol in shock due to acute myocardial infarction. JAMA (1967) 1.31
Hemodynamic studies of patients with myocardial infarction. Circulation (1954) 1.31
Experimental myocardial infarction: circulatory, biochemical and pathologic changes. Am J Med Sci (1956) 1.29
The spectrum of pulmonary vascular disease in transposition of the great arteries. Circulation (1969) 1.29
Studies in clinical shock and hypotension: VI. Relationship between left and right ventricular function. J Clin Invest (1969) 1.28
The treatment of shock associated with myocardial infarction. Circulation (1954) 1.27
Coronary blood flow measured by I-131 iodo-antipyrine. Circ Res (1963) 1.20
STUDIES IN CLINICAL SHOCK AND HYPOTENSION; THE VALUE OF BEDSIDE HEMODYNAMIC OBSERVATIONS. JAMA (1964) 1.17
Patterns of human myocardial oxygen extraction during rest and exercise. J Clin Invest (1962) 1.14
Circulatory changes in acute myo cardial infarction. Circulation (1954) 1.13
Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol. Circulation (1967) 1.12
The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock. Am Heart J (1967) 1.11
Relationship of pyruvate and lactate during anaerobic metabolism. V. Coronary adequacy. Am J Physiol (1961) 1.09
Mechanical intraaortic cardiac assistance in cardiogenic shock. Hemodynamic effects. Arch Surg (1968) 1.09
Myocardial anaerobic metabolism in intact dogs. Am J Physiol (1963) 1.08
Myocardial lactate and pyruvate metabolism. J Clin Invest (1962) 1.07
COMPONENTS OF ALVEOLAR-ARTERIAL O2 DIFFERENCE IN NORMAL MAN. J Appl Physiol (1964) 1.06
Catecholamine-induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work. Am J Cardiol (1962) 1.06
Myocardial infarction with shock. Hemodynamic studies and results of therapy. Circulation (1966) 1.03
CIRCULATORY EFFECTS OF ANGIOTENSIN, LEVARTERENOL AND METARAMINOL IN THE TREATMENT OF SHOCK. N Engl J Med (1964) 1.02
Effect of ischemia and reoxygenation on glycolytic reactions and adenosine-triphosphate in heart muscle. Circ Res (1960) 1.01
Heterogeneity of coronary blood flow in human coronary artery disease and experimental myocardial infarction. Am J Cardiol (1969) 0.98
Coronary and precoronary care. Am J Med (1969) 0.98
Myocardial hypoxia and anerobic metabolism in coronary heart disease. Am J Cardiol (1968) 0.95
Lactate and pyruvate kinetics in isolated perfused rat hearts. Am J Physiol (1969) 0.94
The treatment of cardiogenic shock. I. The nature of cardiogenic shock. Am Heart J (1967) 0.93
Effects of hypoxia on the myocardial metabolism of intact dogs. Circ Res (1954) 0.92
The treatment of cardiogenic shock. VI. The search for an ideal drug. Am Heart J (1968) 0.91
Hemodynamic measurements in experimental coronary shock. J Appl Physiol (1957) 0.91
The physiologic basis for treatment of shock associated with myocardial infarction. Med Clin North Am (1967) 0.90
METABOLIC RESPONSES DURING MYOCARDIAL REACTIVE HYPEREMIA IN THE UNANESTHETIZED DOG. Am J Physiol (1965) 0.90
Effects of arterial hypoxemia and hyperoxia on oxygen availability for myocardial metabolism. Patients with and without coronary heart disease. Am J Cardiol (1969) 0.87
Mechanism of cardiac damage in anoxia. Am J Physiol (1959) 0.87
DISTRIBUTION AND GRADIENT OF LACTATE BETWEEN BLOOD AND HEART MUSCLE. Proc Soc Exp Biol Med (1965) 0.84
Anaerobic heat production by the heart. J Clin Invest (1966) 0.83
Pressor agents in cardiogenic shock. Am J Cardiol (1969) 0.82
Anaerobic metabolism of heart. Circ Res (1962) 0.82
Effect of drugs on myocardial contractility in the intact dog and in experimental myocardial infarction. Am J Cardiol (1968) 0.81
Mechanical increase of vascular resistance in experimental myocardial infarction with shock. Circ Res (1966) 0.81
Counterpulsation effects of coronary blood flow and cardiac oxygen utilization. Circ Res (1966) 0.80
Myocardial lactate oxidation in situ and the effect thereon of reduced coronary flow. Am J Physiol (1966) 0.80
The treatment of cardiogenic shock. IV. The use of phenoxybenzamine and chlorpromazine. Am Heart J (1968) 0.79
Synchronous pressure assist-counterpulsation. Prog Cardiovasc Dis (1969) 0.79
Left ventricular contraction and the therapy of cardiogenic shock. Circulation (1967) 0.78
INDICATOR-DILUTION CURVES OBTAINED ACROSS THE SYSTEMIC CIRCULATION DURING CARDIOPULMONARY BYPASS PERFUSION. Surgery (1965) 0.78
The evaluation and treatment of cardiogenic shock. Med Times (1970) 0.78
Effect of systemic blood pressure and vasopressor drugs on coronary blood flow and the electrocardiogram. Am J Cardiol (1959) 0.77
Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock. Am Heart J (1967) 0.76
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med (1991) 13.21
Primary pulmonary hypertension. A national prospective study. Ann Intern Med (1987) 6.80
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation (1996) 3.98
Mutant p53 protein associated with chemosensitivity in breast cancer specimens. Lancet (1994) 2.29
Biochemical and immunological characterization of desmoplakins I and II, the major polypeptides of the desmosomal plaque. J Mol Biol (1983) 2.27
Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med (1973) 2.00
Fractionation of troponin into two distinct proteins. Biochem Biophys Res Commun (1968) 1.96
Evaluation of patient, physician, nurse, and family attitudes toward do not resuscitate orders. Arch Intern Med (1990) 1.87
Desmoplakins of epithelial and myocardial desmosomes are immunologically and biochemically related. Differentiation (1982) 1.73
The preparation of tropomyosin and troponin from natural actomyosin. Biochim Biophys Acta (1969) 1.62
Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation (1974) 1.60
Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res (1998) 1.57
Accidental hypothermia in an alcoholic population. Am J Med (1974) 1.52
Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukoc Biol (1990) 1.51
Calcified left atrial myxoma simulating mitral insufficiency. Hemodynamic and phonocardiographic effects of tumor movement. Circulation (1967) 1.49
Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training. Circulation (1994) 1.46
ON THE MAGNETIC ASYMMETRY OF MUSCLE FIBERS. Proc Natl Acad Sci U S A (1958) 1.45
Immunocytochemical identification of epithelium-derived human tumors with antibodies to desmosomal plaque proteins. Proc Natl Acad Sci U S A (1983) 1.44
Systemic and myocardial hemodynamic responses to relatively small concentrations of carboxyhemoglobin (COHB). Arch Environ Health (1969) 1.44
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol (1991) 1.43
Myocardial and systemic responses to carboxyhemoglobin. Ann N Y Acad Sci (1970) 1.40
Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci U S A (1997) 1.39
Early emergent coronary bypass after failed angioplasty. Del Med J (1993) 1.39
Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg (1975) 1.36
The mobile coronary care unit. Dis Chest (1969) 1.27
The effect of various protein fractions on Z- and M-line reconstitution. J Cell Biol (1969) 1.26
Significance of two desmosome plaque-associated polypeptides of molecular weights 75 000 and 83 000. EMBO J (1983) 1.24
Structural basis of pheromone binding to mouse major urinary protein (MUP-I). Protein Sci (2001) 1.22
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Inappropriate ventilation and hypoxemia as causes of cardiac arrhythmias. The control of arrhythmias without antiarrhythmic drugs. Am J Med (1969) 1.19
Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia (2004) 1.18
Cross-sectional and longitudinal changes in pulmonary function associated with automobile pollution among bridge and tunnel officers. Am J Ind Med (1988) 1.18
Characterization of the molecular region containing the active sites of myosin. J Biol Chem (1965) 1.18
The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. Am Rev Respir Dis (1989) 1.16
Mastoparan interacts with the carboxyl terminus of the alpha subunit of Gi. J Biol Chem (1990) 1.14
Evaluation of the do not resuscitate orders at a community hospital. Arch Intern Med (1989) 1.12
Esophageal obstruction during oxygen administration: a new method for use in resuscitation. Chest (1974) 1.11
Health effects of exposure to high concentrations of automotive emissions. Studies in bridge and tunnel workers in New York City. Arch Environ Health (1973) 1.11
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J Clin Invest (1980) 1.11
IONIC SEMIPERMEABILITY AS A BULK PROPERTY. Proc Natl Acad Sci U S A (1957) 1.08
Isolation and symmetrical splitting of desmosomal structures in 9 M urea. Eur J Cell Biol (1983) 1.08
Undergraduate education in critical care medicine. Crit Care Med (1992) 1.08
Studies on troponin. Biochim Biophys Acta (1969) 1.07
The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest (1971) 1.05
Separation and recombination of the ethylene glycol bis (beta-aminoethyl ether)-N,N'-tetraacetic acid-sensitizing factor obtained from a low ionic strength extract of natural actomyosin. J Biol Chem (1967) 1.02
Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer (1994) 1.02
Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr (1982) 1.01
Systemic hemodynamic and myocardial metabolic effects of isoproterenol and angiotensin after open-heart surgery. Circulation (1970) 1.00
Meningococcic pericarditis. A case report and review of the literature. Am J Cardiol (1966) 0.99
The metabolism of myosin and the meromyosins from rabbit skeletal muscle. J Biol Chem (1966) 0.97
Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction. Circulation (1972) 0.97
Carboxyhemoglobin: Hemodynamic and Respiratory Responses to Small Concentrations. Science (1965) 0.97
Burns in childhood: an epidemiological survey. Aust N Z J Surg (1978) 0.96
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia (2013) 0.94
Effect of Bailey's tropomyosin purification on EGTA-sensitizing activity. Nature (1966) 0.94
The mobile coronary care unit and the intermediate coronary care unit in the total systems approach to coronary care. Chest (1970) 0.93
Allergenicity of alpha-caseins from cow, sheep, and goat. Allergy (1997) 0.93
Polyphosphoinositide metabolism is rapidly stimulated by activation of a temperature-sensitive mutant of Rous sarcoma virus in rat fibroblasts. Oncogene (1987) 0.92
Therapeutic surgical division of the human conduction system. JAMA (1967) 0.92
Three states for the formyl peptide receptor on intact cells. J Biol Chem (1989) 0.91
Extreme hypocapnia in the critically ill patient. Am J Med (1974) 0.91
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol (2012) 0.90
Psychiatric complications following open heart surgery. Compr Psychiatry (1971) 0.90
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. J Am Coll Cardiol (1990) 0.89
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J Neural Transm (Vienna) (2006) 0.89
Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man. Circulation (1978) 0.88
Neutrophil activation by inflammatory microcrystals of monosodium urate monohydrate utilizes pertussis toxin-insensitive and -sensitive pathways. J Immunol (1990) 0.88
Allergenic epitopes of bovine alpha S1-casein recognized by human IgE and IgG. Allergy (1996) 0.88
Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance. Biochemistry (1990) 0.87
Temporary transvenous pacing via the percutaneous femoral vein approach. A prospective study of 100 cases. Am Heart J (1973) 0.87
Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy. Clin Exp Immunol (2011) 0.87
Endotracheal damage during continuous ventilatory support. Ann Surg (1974) 0.87
Effect of pulmonary blood flow upon lung mechanics. J Clin Invest (1967) 0.86
Mortality rate from acute myocardial infarction--what are we talking about? Am J Cardiol (1967) 0.86
Protocol for the management of arrhythmias in acute myocardial infarction. Crit Care Med (1975) 0.86
The role of propranolol in the treatment of acute myocardial infarction. Prog Cardiovasc Dis (1977) 0.86
A comparison of two behavioral measures of psychomotor activation following intravenous amphetamine or cocaine: dose- and sensitization-dependent changes. Behav Pharmacol (1999) 0.85
The management of sinus bradycardia, nodal rhythm and heart block for the prevention of cardiac arrest in acute myocardial infarction. Prog Cardiovasc Dis (1968) 0.85